Study on the Effectiveness of Injectable Human ADM (Cellular Dermal Matrix) to Induce Regeneration of Incisional Muscle after Spinal Surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009291

Enrollment

Registered

2024-03-29

Start date

2024-04-17

Completion date

Unknown

Last updated

2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : 1) Perform scheduled surgery on the agreed patients and inject 3cc of CGReallo Inject into each backmuscle before closing the window. 2) At 3, 6, and 12 months after surgery, we will

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.40 adults aged 19 years old 2. A patient who implementation is performed through rear accessories (cooperative symptoms, disk) through rear approaches to the rear infection

Exclusion criteria

Exclusion criteria: 1. Patients with a previous history of surgery with rear access 2. Patients performing lateral incisions rather than midline incisions 3. surgery due to tumor, trauma or infection 4. surgery due to spinal deformity

Design outcomes

Primary

Measure	Time frame
Measure flexibility recovery with lateral flexion, extension radiography	—

Secondary

Measure	Time frame
VAS, ODI, EQ-5D Questionnaire	—

Countries

Korea, Republic of

Contacts

Public ContactJI Sunohk

Asan Medical Center

kenzo718@nate.com+82-2-3010-4668

Outcome results